- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 31, Issue 13, 2024
Current Medicinal Chemistry - Volume 31, Issue 13, 2024
Volume 31, Issue 13, 2024
-
-
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma
Authors: Marco Zeppieri and Mutali MusaPseudoexfoliative glaucoma (PEG) is a type of secondary open-angle glaucoma characterized by the accumulation of whitish-gray material on the trabecular meshwork and lens, leading to an increase in intraocular pressure (IOP) and optic nerve damage. Local eye drop therapy is one of the first-line treatments for PEG, which include prostaglandin analogues, beta-blockers, and alpha-adrenergic agonists to lower IOP. New tre Read More
-
-
-
Early-Life Lead Exposure: Risks and Neurotoxic Consequences
Authors: Geir Bjørklund, Torsak Tippairote, Tony Hangan, Salvatore Chirumbolo and Massimiliano PeanaBackground: Lead (Pb) does not have any biological function in a human, and it is likely no safe level of Pb in the human body. The Pb exposure impacts are a global concern for their potential neurotoxic consequences. Despite decreasing both the environmental Pb levels and the average blood Pb levels in the survey populations, the lifetime redistribution from the tissues-stored Pb still poses neurotoxic risks from the low-le Read More
-
-
-
CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy
Authors: Yeteng Mu and Xingang GuanImmune checkpoint inhibitors (ICIs) have shown unprecedented efficacy in treating many advanced cancers. Although FDA-approved ICIs have shown promising efficacy in treating many advanced cancers, their application is greatly limited by the low response rate, immune-related adverse events (irAE), and drug resistance. Developing novel ICIs holds great promise to improve the survival and prognosis of advanced cancer Read More
-
-
-
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine
The foundations of cell reprogramming were laid by Yamanaka and co-workers, who showed that somatic cells can be reprogrammed into pluripotent cells (induced pluripotency). Since this discovery, the field of regenerative medicine has seen advancements. For example, because they can differentiate into multiple cell types, pluripotent stem cells are considered vital components in regenerative medicine aimed at Read More
-
-
-
Multiple Natural Polymers in Drug and Gene Delivery Systems
Authors: Zhengfa Jiang, Zongmian Song, Chen Cao, Miaoheng Yan, Zhendong Liu, Xingbo Cheng, Hongbo Wang, Qingnan Wang, Hongjian Liu and Songfeng ChenNatural polymers are organic compounds produced by living organisms. In nature, they exist in three main forms, including proteins, polysaccharides, and nucleic acids. In recent years, with the continuous research on drug and gene delivery systems, scholars have found that natural polymers have promising applications in drug and gene delivery systems due to their excellent properties such as biocompatibilit Read More
-
-
-
Role of LncRNA MIAT in Diabetic Complications
Authors: Lijun Wang, Hailin Wang, Yiyang Luo, Wei Wu, Yibei Gui, Jiale Zhao, Ruisi Xiong, Xueqin Li, Ding Yuan and Chengfu YuanLong non-coding RNA (LncRNA) refers to a large class of RNAs with over 200 nucleotides that do not have the function of encoding proteins. In recent years, more and more literature has revealed that lncRNA is involved in manipulating genes related to human health and disease, playing outstanding biological functions, which has attracted widespread attention from researchers. The newly discovered long-stranded non-c Read More
-
-
-
The Effect of Statin Therapy on Serum Uric Acid Levels: A Systematic Review and Meta-analysis
Authors: Abolfazl Akbari, Mahya Razmi, Mahdi Rafiee, Gerald F. Watts and Amirhossein SahebkarBackground: Elevated concentrations of serum uric acid (SUA) are associated with several conditions, including cardiovascular disease. The present study aimed to estimate the impact of statin therapy on SUA levels through a systematic review and meta-analysis of clinical trials. Methods: PubMed, Embase, Web of Science, and Scopus were searched on January 14, 2022, to identify eligible clinical trials. The intervention gro Read More
-
-
-
Inflammatory Response Modulation by Low-Dose Anti-inflammatory Drugs Treatment in an In Vitro Osteoarthritis Cellular Model
Authors: Marco Iuliano, Valter Santilli, Andrea Mineo, Marco Paoloni, Paolo Rosa, Giorgio Mangino and Giovanna RomeoBackground: Low-dose-medicine is based on the administration of low doses of biological regulators to restore the immunologic balance altered in the disease. Cytokines are pivotal regulators of cellular and tissue functions and impaired crosstalk, due to an imbalance between specific cytokines, it is fundamental in acute inflammation and diseases correlated to low-grade chronic inflammation. Osteoarthritis is the most Read More
-
-
-
Identification of a Novel Diagnosis Model based on 5 Hub Genes for Chronic Thromboembolic Pulmonary Hypertension
Authors: Feng Zhang, Xiaoming Huang, Junqi Lin, Ruilin Yu, Shaoming Lin, Guanle Shen and Wenbiao ChenBackground: As a type of precapillary pulmonary hypertension, chronic thromboembolic pulmonary hypertension (CTEPH) results from incomplete pulmonary embolism resolution. In this study, we aimed to determine biomarker genes for predicting the prognosis of CTEPH. Methods: RNAseq of CTEPH was collected from the public database, namely Gene Expression Omnibus (GEO), including GSE84538 and GSE188938, which co Read More
-
-
-
Metabolome Profiling of Malignant Ascites Identifies Candidate Metabolic Biomarkers of Hepatocellular Carcinoma
Authors: Weijia Wang, Yue Wu, Qinsheng Zhang and Peilin CuiBackground: Malignant ascites is one of the severe complications of hepatocellular carcinoma, which can be regarded as a unique tumor microenvironment of hepatocellular carcinoma. The identification of novel biomarkers in malignant ascites could be crucial to differentiate patients with hepatocellular carcinoma and cirrhotic ascites. Objective: The study aimed to distinguish the metabolomics of malignant ascites in Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
- Issue 42
- Issue 41
- Issue 40
- Issue 39
- Issue 38
- Issue 37
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 18
- Issue 17
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
